SEA-Healthcare Overview
The annual SEA Healthcare & Pharma Show, SEACare, brings forth healthcare-medical professionals and pharmaceutical sectors in Southeast Asia to showcase cutting-edge innovations, build strategic partnerships, and engage in transformative discussions shaping the industry's future.
In 2024, SEACare was acquired by the B2B platform and trade show specialist, Qube Integrated Malaysia Sdn Bhd. Under the new ownership and management, SEACare was reimagined as a business matching platform for healthcare and pharmaceutical brands and manufacturers to connect, network and collaborate with distributors focusing on the Malaysian and Southeast Asian markets.
SEACare 2024 was launched with the endorsement of the Ministry of Health, Malaysia, and Malaysia External Trade Development Corporation - MATRADE. The new format of the show was well-received by the industry, and garnering notable achievements including total potential sales of RM 685.3 million and becoming one of the few triple-accredited events (MMA, MDC, and MPS). SEACare 2024 attracted over 8,107 trade visitors from 61 countries and featured over 300 exhibitors representing 100 companies from 15 countries.
SEACare 2025 aims to build on this success with a projected 25% growth across the board. We anticipate approximately 15,000 trade visitors and over 500 booths, with an expected potential sales volume of RM 1 billion. Capitalising on Malaysia’s role as a regional hub for medical and pharmaceutical progress, SEACare 2025 will feature an exceptional lineup of exhibitors.
SEACare stands as a testament to the growing importance of the healthcare and pharmaceutical sectors in Southeast Asia. By positioning itself at the forefront of the healthcare revolution, SEACare is dedicated to shaping a healthier tomorrow for all, making it an essential event for anyone involved in the healthcare and pharmaceutical fields.
